Paediatric Medicines

The birth of the UNIVERSAL project – a back story

2021

A while ago, we sat with Marc Lallemant – the scientific coordinator of the UNIVERSAL project led by Penta, for a quick chat. It was an eye-opening discussion that delved into the early beginnings and the birth of the project.

According to Marc, TUTI pronounced as “tutti” in Italian (meaning everyone) was the name initially settled for. He further went on to clarify that TUTI had no Italian origin and was an acronym with a full meaning – Towards Universal Treatment of children in Africa.

Read More

GAP-f webinar on Best practices in clinical research for the development of paediatric formulations

2021

We are pleased to invite you to the kick-off of #BetterDrugs4Kids, GAP-f’s new quarterly webinar series on paediatric drug optimization, featuring deep dives on paediatric drug prioritization, evaluation, development, and delivery, and promoting discussions to close the paediatric treatment gaps.

The first webinar, on “Best practices in clinical research for the development of paediatric formulations”, is hosted by GAP-f’s Clinical Research Working Group,

Read More

Cascade of care in children and adolescents with HIV in the Russian Federation

2020

The Cascade of Care, more commonly known as the HIV care continuum, is a calculation of how many people in a specific population diagnosed with HIV are initially linked to care, retained in care and have achieved viral suppression. It is an important tool in measuring success in controlling the HIV infection, identifying gaps in national HIV/AIDS strategies and set directions to improve care.

On behalf of EPIICC and REACH researchers,

Read More

Cascade of care in children and adolescents with HIV in Russian Federation

2020

Author: Anna Turkova, Evgeny Voronin, Yulia Plotnikova, Anna Samarina, Edith Milanzi, Vladimir Rozenberg, Liubov Okhonskaia, Inga Latysheva, Aleksey Plynsky, Elena Fertikh, Siobhan Crichton, Charlotte Jackson, Ali Judd, Intira J Collins, on behalf of the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

Published in: 12th International Workshop on HIV Pediatrics

View Poster

 

Background:

The cascade of care summarises the 90-90-90 UNAIDS targets,

Read More

Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis

2020

Authors: Singh R, Baker M, Thapar M, Gibb D, Turkova A, Ford D, Ruel T, Wiznia A, Farhad M, Alvero C, Green J, Bollen P, Colbers A, Burger D, Acosta E

Published in: 12th International Workshop on HIV Pediatrics

View Abstract booklet

 

Background: HIV treatment options remain limited in children. The recent Tivicay (dolutegravir,

Read More

ILF: Advance procurement of paediatric drug formulations – Policy brief

2019

The many challenges of developing drugs appropriately formulated for children are compounded by a series of market factors that make these efforts costly and complex, discouraging drug manufacturers – especially generic drug manufacturers – from prioritizing investments in new paediatric treatment options.

In alignment with the Rome Action Plan, the IAS Industry Liaison Forum (ILF) developed a policy brief exploring the opportunities of advance procurement as a pragmatic approach for the largest ARV buyers – most notably national governments (particularly the Government of South Africa),

Read More

A video of the ID-EPTRI Kick-off meeting now available!

2018

The ID-EPTRI Kick-off meeting was a success. The active participation and the strong interest shown by more of the 100 participants has confirmed that the ID-EPTRI project can count on a collaborative and proficient partnership that could allow reaching all the challenging objectives foreseen towards the establishment of the European Paediatric Translational Research Infrastructure.

The Kick-off meeting was just the first important step reached in the ID-EPTRI project and it represents the beginning of a collaborative work,

Read More